Menu

Blog

Archive for the ‘biotech/medical’ category: Page 2352

Oct 24, 2017

I Am The Lifespan

Posted by in categories: biotech/medical, life extension

Over the past few years, there has been a tradition of longevity researchers and activists around the world to organize events on or around October 1 — the UN International Day of Older Persons, or Longevity Day. In recent years this has been extended to include the entire month of November as a Longevity Month where activists organize various activities and events to raise awareness for aging research.

This year we have continued this tradition with the Longevity Month “I am the Lifespan” event, where people tell us their story and how they got interested in aging research and doing something about age-related diseases. and it has been a great success so far. Lots of people have sent in their stories and we have been publishing them on our Facebook page the last few weeks. We wanted to share some of these stories with you and a little about the people behind them.

Read more

Oct 24, 2017

The Societal Benefits of Rejuvenation Biotechnology

Posted by in categories: biotech/medical, life extension

Recently, we have explored the benefits that rejuvenation biotechnologies promise to bring to ourselves and the people close to us. I would imagine that most people have no difficulty acknowledging these benefits, but even so, many people tend to focus on potential large-scale downsides of rejuvenation while neglecting entirely its benefits on society at large.

The following is a brief discussion of how, in my opinion, anti-aging biotechnologies would positively impact the whole of humanity—assuming they were widely employed, as they should be.

Read more

Oct 23, 2017

Suicide molecules kill any cancer cell

Posted by in category: biotech/medical

CHICAGO — Small RNA molecules originally developed as a tool to study gene function trigger a mechanism hidden in every cell that forces the cell to commit suicide, reports a new Northwestern Medicine study, the first to identify molecules to trigger a fail-safe mechanism that may protect us from cancer.

The mechanism — RNA suicide molecules — can potentially be developed into a novel form of cancer therapy, the study authors said.

Cancer cells treated with the RNA molecules never become resistant to them because they simultaneously eliminate multiple genes that cancer cells need for survival.

Continue reading “Suicide molecules kill any cancer cell” »

Oct 23, 2017

How Creating a Gene Circuit Could Help to Combat Cancer

Posted by in categories: bioengineering, biotech/medical

A research team at MIT has used synthetic biology to create a gene circuit that triggers the immune system to attack cancer when it first detects the signs of the disease.

The circuit works by only activating the immune response when two specific cancer biomarkers are detected. The new study was published in the journal Cell this week and represents an exciting step forward for synthetic biology and cancer research.

Read more

Oct 22, 2017

Man Modifies His Own Genes

Posted by in category: biotech/medical

This man is modifying his genes to make himself stronger.

Read more

Oct 22, 2017

Drug Companies Make Eyedrops Too Big — And You Pay for the Waste

Posted by in categories: biotech/medical, health

ProPublica has been documenting the many ways health care dollars are being wasted. We’ve shown how hospitals throw out brand new supplies, nursing homes flush tons of unexpired medication and drug companies concoct costly combinations of cheap medication. Recently we described how arbitrary drug expiration dates cause us to toss safe and potent medicine.

Often, large swaths of the medical and pharmaceutical communities know about this waste — even about solutions to it — but do nothing. Those who end up paying the bill, in one way or another, are consumers.

Continue reading “Drug Companies Make Eyedrops Too Big — And You Pay for the Waste” »

Oct 21, 2017

Scientists reverse aging in human cell lines and give theory of aging a new lease of life

Posted by in categories: biotech/medical, life extension

Can the process of aging be delayed or even reversed? Research led by specially appointed Professor Jun-Ichi Hayashi from the University of Tsukuba in Japan has shown that, in human cell lines at least, it can. They also found that the regulation of two genes involved with the production of glycine, the smallest and simplest amino acid, is partly responsible for some of the characteristics of aging.

Read more

Oct 21, 2017

World’s First Human Head Transplant Will Take Place in December

Posted by in category: biotech/medical

Last year, Dr. Sergio Canavero created quite the ruckus (to put it mildly) when he vowed to be the first person to transplant a human head onto a deceased donor’s body. Yes, he is planning on attempting the world’s first human head transplant (or body transplant, depending on how you look at it).

In fact, it has been about a year since his initial proclamation, and the Italian neurosurgeon still stands firm on his declaration, despite claims from other experts that it is nothing but a PR Stunt (at best) or a hoax. Some have even hypothesized it’s all just a plot meant to promote Metal Gear Solid.

Read more

Oct 21, 2017

Trust My Science

Posted by in categories: biotech/medical, science

Transmedics, une machine qui permet de « réanimer » un coeur ayant cessé de battre. Une belle avancée pour augmenter considérablement le nombre de greffons disponibles pour les transplantations!

Via Explore Science

Read more

Oct 21, 2017

Here’s How Pharma Is Using AI Deep Learning To Cure Aging

Posted by in categories: biotech/medical, life extension, robotics/AI

LEF has access to blood tests from its customers who take the product. That means data should be available in less than a year. If it works, we can expect other DNN-developed geroprotectors.


In 2011, scientists made one of the most important discoveries in the history of AI development. They found that graphics processing units (GPUs) are far better at simulating biological learning than central processing units (CPUs).

Read more